University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis

Not Applicable

Completed

Conditions: Systemic Sclerosis
Scleroderma

Interventions: Drug: Ambrisentan

First Posted Date: 2010-03-26

Last Posted Date: 2018-11-29

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 15

Registration Number: NCT01093885

Locations: 🇺🇸
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

Long Term Chamomile Therapy for Anxiety

Phase 3

Completed

Conditions: Generalized Anxiety Disorder

Interventions: Drug: Chamomile (Matricaria recutita)

First Posted Date: 2010-02-22

Last Posted Date: 2017-07-06

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 180

Registration Number: NCT01072344

Locations: 🇺🇸
Depression Research Unit, Philadelphia, Pennsylvania, United States

Behavioral Economics and Food Choice

Not Applicable

Completed

Conditions: Obesity
Overweight

Interventions: Behavioral: Calorie information
Behavioral: Exercise Equivalent only
Behavioral: Calorie & Exercise equivalent information

First Posted Date: 2010-02-03

Last Posted Date: 2011-11-16

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 4

Registration Number: NCT01061905

Locations: 🇺🇸
ARAMARK healthcare at Main Line Health, Bryn Mawr, Pennsylvania, United States
🇺🇸
ARAMARK Healthcare at Henry Ford Hospital, Detroit, Michigan, United States
🇺🇸
ARAMARK healthcare at North Shore University Health System, Evanston, Illinois, United States

and more 1 locations

Ovarian Freezing Before Cancer Treatment

Terminated

Conditions: Effects of Chemotherapy

First Posted Date: 2010-01-27

Last Posted Date: 2021-04-15

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 31

Registration Number: NCT01057745

Locations: 🇺🇸
Penn Fertility Care, 3701 Market Street, Suite 800, Philadelphia, Pennsylvania, United States

Naltrexone for Impulse Control Disorders in Parkinson's Disease

Phase 4

Completed

Conditions: Parkinson Disease
Impulse Control Disorder

Interventions: Drug: Placebo
Drug: Naltrexone

First Posted Date: 2010-01-20

Last Posted Date: 2015-08-06

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 50

Registration Number: NCT01052831

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) Among Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Personnel

Not Applicable

Completed

Conditions: Combat Disorders
Posttraumatic Stress Disorders

Interventions: Behavioral: Prolonged Exposure Therapy - Massed
Behavioral: Present-Centered Therapy
Behavioral: Minimal Contact Control
Behavioral: Prolonged Exposure Therapy - Spaced

First Posted Date: 2010-01-14

Last Posted Date: 2018-11-27

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 366

Registration Number: NCT01049516

Locations: 🇺🇸
Carl R. Darnall Army Medical Center, Killeen, Texas, United States
🇺🇸
Center for the Treatment and Study of Anxiety, University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

Fenofibrate and Omega-3 Fatty Acid Modulation of Endotoxemia

Not Applicable

Completed

Conditions: Cardiovascular Disease

Interventions: Drug: Fenofibrate (Tricor) tablets
Drug: Placebo
Drug: Lovaza

First Posted Date: 2010-01-13

Last Posted Date: 2016-02-19

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 100

Registration Number: NCT01048502

Locations: 🇺🇸
Clinical and Translational Research Center (CTRC); Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence

Phase 4

Completed

Conditions: Nicotine Dependence

Interventions: Drug: Transdermal nicotine patch

First Posted Date: 2010-01-13

Last Posted Date: 2015-07-08

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 525

Registration Number: NCT01047527

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Treatment of Insomnia in Elderly Sleep Apnea Patients With Ramelteon (TAK 375)

Phase 3

Completed

Conditions: Obstructive Sleep Apnea
Insomnia

Interventions: Drug: rozerem
Drug: Placebo

First Posted Date: 2010-01-13

Last Posted Date: 2023-05-25

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 27

Registration Number: NCT01048242

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Surgery Or Lifestyle Intervention for Type 2 Diabetes (SOLID)

Phase 3

Completed

Conditions: Type 2 Diabetes

Interventions: Procedure: Roux-en-Y Gastric Bypass surgery
Procedure: Laparoscopic Adjustable Gastric Banding surgery
Behavioral: Intensive Lifestyle Modification

First Posted Date: 2009-12-29

Last Posted Date: 2016-08-19

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 7

Registration Number: NCT01040468

Locations: 🇺🇸
University of Pennsylvania Center for Weight and Eating Disorders, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy